NEXAVAR Side Effects

7022879-X | Anaemia, Deafness Unilateral, Decreased Appetite, Diarrhoea, Faeces Hard, Gastric Haemorrhage, Hepatic Function Abnormal, Hepatic Neoplasm Malignant, Hyperamylasaemia
on Sep 28, 2010 Male patient from JAPAN , 70 years of age, weighting 143.3 lb, was diagnosed with hepatic neoplasm malignant, cholelithiasis, insomnia and was treated with Nexavar (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, deafness unilateral, decreased appetite, diarrhoea, faeces hard, gastric haemorrhage, hepatic function abnormal, hepatic neoplasm malignant, hyperamylasaemia. Nexavar dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. During the same period patient was treated with URSO 250 (Since Before Administration) (View Urso 250 Review and Urso 250 Label ), SUPACAL (Since Before Administration) (View Supacal Review and Supacal Label ), MYSLEE (Since Before Administration) (View Myslee Review and Myslee Label ).

7022878-8 | Akathisia, Alopecia, Decreased Appetite, Hepatic Function Abnormal, Hypertension, Nausea, Palmar-plantar Erythrodysaesthesia Syndrome, Pneumonia, Pulmonary Tuberculosis
Patient was taking Nexavar (View Usage). Patient had the following side effects: akathisia, alopecia, decreased appetite, hepatic function abnormal, hypertension, nausea (What is nausea?), palmar-plantar erythrodysaesthesia syndrome, pneumonia (What is pneumonia?), pulmonary tuberculosis on Sep 27, 2010 from JAPAN Additional patient health information: Male patient , 63 years of age, weighting 125.7 lb, was diagnosed with hepatic neoplasm malignant, nausea (What is nausea?) and. Nexavar dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. During the same period patient was treated with SUTENT (View Sutent Review and Sutent Label ), NOVAMIN (View Novamin Review and Novamin Label ), OXYCONTIN (Since Before Administration) (View Oxycontin Review and Oxycontin Label ), GASMOTIN (Unit Dose: 5 Mg) (View Gasmotin Review and Gasmotin Label ). Patient was hospitalized.

7022876-4 | Stevens-johnson Syndrome
Adverse event was reported on Sep 28, 2010 by a Male patient taking Nexavar (View Usage) (Dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg) was diagnosed with hepatic neoplasm malignant and. Location: JAPAN , 74 years of age, After Nexavar was administered, patient had the following side effects: stevens-johnson syndrome. Patient was hospitalized.

7022875-2 | Asthenia, Atrioventricular Block, Torsade De Pointes
on Sep 24, 2010 Male patient from FRANCE , 70 years of age, weighting 169.8 lb, was diagnosed with hepatic neoplasm malignant and was treated with Nexavar (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, atrioventricular block, torsade de pointes. Nexavar dosage: Total Daily Dose: 400 Mg. Patient was hospitalized.


7022873-9 | Metastases To Diaphragm, Metastases To Spine
on Sep 27, 2010 Female patient from RUSSIAN FEDERATION , 20 years of age, was diagnosed with renal cancer and was treated with Nexavar (View Usage). Patient had the following side effects: metastases to diaphragm, metastases to spine. Nexavar dosage: Total Daily Dose: 400 Mg.

7022030-6 | Blood Potassium Decreased, Conduction Disorder
Patient was taking Nexavar (View Usage). After Nexavar was administered, patient had the following side effects: blood potassium decreased, conduction disorder on Sep 16, 2010 from GERMANY Additional patient health information: Male patient , 61 years of age, was diagnosed with hepatic neoplasm malignant, blood potassium decreased and. Nexavar dosage: Total Daily Dose: 400 Mg. During the same period patient was treated with 4SC 201 (Total Daily Dose: 600 Mg) (View 4sc-201 Review and 4sc-201 Label ), KALINOR (View Kalinor Review and Kalinor Label ). Patient was hospitalized.

7022006-9 | Hypothyroidism, Thyroiditis
Adverse event was reported on Sep 27, 2010 by a Female patient taking Nexavar (View Usage) (Dosage: Unit Dose: 200 Mg) was diagnosed with renal cell carcinoma, pulmonary hypertension (What is pulmonary hypertension?) and. Location: GERMANY , 53 years of age, Patient experienced the following unwanted or unexpected effects: hypothyroidism, thyroiditis. During the same period patient was treated with SUTENT (View Sutent Review and Sutent Label ), AMLODIPINE (1 Day) (View Amlodipine Review and Amlodipine Label ). Patient was hospitalized.

7020273-9 | Hepatic Function Abnormal, Hyperkalaemia, Palmar-plantar Erythrodysaesthesia Syndrome
on Sep 27, 2010 Male patient from JAPAN , 69 years of age, weighting 121.3 lb, was diagnosed with renal cell carcinoma, hepatic function abnormal and was treated with Nexavar (View Usage). Patient had the following side effects: hepatic function abnormal, hyperkalaemia, palmar-plantar erythrodysaesthesia syndrome. Nexavar dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. During the same period patient was treated with MINOPHAGEN C (View Minophagen C Review and Minophagen C Label ), MOBIC (View Mobic Review and Mobic Label ), MICARDIS (View Micardis Review and Micardis Label ), OXINORM (View Oxinorm Review and Oxinorm Label ). Patient was hospitalized.

7020263-6 | Dermatitis Exfoliative, Skin Necrosis
on Sep 24, 2010 Male patient from CZECH REPUBLIC , 68 years of age, was diagnosed with renal cancer and was treated with Nexavar (View Usage). After Nexavar was administered, patient had the following side effects: dermatitis exfoliative, skin necrosis. Nexavar dosage: Unit Dose: 200 Mg. During the same period patient was treated with ROFERON A (View Roferon-a Review and Roferon-a Label ), TRALGIT (Total Daily Dose: 60 Gtt) (View Tralgit Review and Tralgit Label ), BONDRONAT (View Bondronat Review and Bondronat Label ).

7020260-0 | Erythema Multiforme, Hepatic Function Abnormal, Injury, Palmar-plantar Erythrodysaesthesia Syndrome, Pyrexia
Patient was taking Nexavar (View Usage). Patient experienced the following unwanted or unexpected effects: erythema multiforme, hepatic function abnormal, injury, palmar-plantar erythrodysaesthesia syndrome, pyrexia on Sep 22, 2010 from JAPAN Additional patient health information: Male patient , 59 years of age, weighting 145.5 lb, was diagnosed with hepatic neoplasm malignant, tumour associated fever and. Nexavar dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. During the same period patient was treated with RENIVACE (Unit Dose: 5 Mg) (View Renivace Review and Renivace Label ), PONTAL (Unit Dose: 250 Mg) (View Pontal Review and Pontal Label ), NAIXAN (Unit Dose: 100 Mg) (View Naixan Review and Naixan Label ). Patient was hospitalized.

7020251-X | Flushing, Gastric Ulcer, Hepatic Function Abnormal, Hypertension, Palmar-plantar Erythrodysaesthesia Syndrome, Rash
Adverse event was reported on Sep 22, 2010 by a Male patient taking Nexavar (View Usage) (Dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg) was diagnosed with hepatic neoplasm malignant and. Location: JAPAN , 60 years of age, weighting 121.3 lb, Patient had the following side effects: flushing, gastric ulcer, hepatic function abnormal, hypertension, palmar-plantar erythrodysaesthesia syndrome, rash (What is rash?).

7020248-X | Hepatic Encephalopathy
on Sep 21, 2010 Male patient from GERMANY , 70 years of age, weighting 176.4 lb, was diagnosed with hepatic neoplasm malignant and was treated with Nexavar (View Usage). After Nexavar was administered, patient had the following side effects: hepatic encephalopathy. Nexavar dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. During the same period patient was treated with RAMIPRIL (Total Daily Dose: 2.5 Mg) (View Ramipril Review and Ramipril Label ), PANTOPRAZOLE (Total Daily Dose: 40 Mg) (View Pantoprazole Review and Pantoprazole Label ), ALLOPURINOL (Total Daily Dose: 300 Mg) (View Allopurinol Review and Allopurinol Label ), SPIRONOLACTONE (Total Daily Dose: 50 Mg) (View Spironolactone Review and Spironolactone Label ). Patient was hospitalized.

7020229-6 | Hepatic Neoplasm Malignant, Liver Abscess, Pyrexia
on Sep 22, 2010 Male patient from JAPAN , 78 years of age, weighting 116.8 lb, was diagnosed with hepatic neoplasm malignant and was treated with Nexavar (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic neoplasm malignant, liver abscess, pyrexia. Nexavar dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. Patient was hospitalized.

7020226-0 | Hepatic Function Abnormal, Hepatic Neoplasm Malignant
Patient was taking Nexavar (View Usage). Patient had the following side effects: hepatic function abnormal, hepatic neoplasm malignant on Sep 22, 2010 from JAPAN Additional patient health information: Male patient , 68 years of age, weighting 149.9 lb, was diagnosed with hepatic neoplasm malignant, hypertension, reflux oesophagitis, gout (What is gout?) and. Nexavar dosage: Unit Dose: 200 Mg. During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ZYLORIC (View Zyloric Review and Zyloric Label ), DIOVAN (View Diovan Review and Diovan Label ). Patient was hospitalized.

7020224-7 | Colitis Ischaemic, Hepatic Neoplasm Malignant
Adverse event was reported on Sep 22, 2010 by a Female patient taking Nexavar (View Usage) (Dosage: Unit Dose: 200 Mg) was diagnosed with hepatic neoplasm malignant, pain management, constipation (What is constipation?) and. Location: JAPAN , 75 years of age, weighting 79.37 lb, After Nexavar was administered, patient had the following side effects: colitis ischaemic, hepatic neoplasm malignant. During the same period patient was treated with AMOXAN (Unit Dose: 10 Mg) (View Amoxan Review and Amoxan Label ), OPALMON (Unit Dose: 5 ?g) (View Opalmon Review and Opalmon Label ), MAGMITT (Unit Dose: 330 Mg) (View Magmitt Review and Magmitt Label ), OXINORM (Unit Dose: 25 Mg) (View Oxinorm Review and Oxinorm Label ), GABAPEN (Unit Dose: 200 Mg) (View Gabapen Review and Gabapen Label ), ZYPREXA (Unit Dose: 2.5 Mg) (View Zyprexa Review and Zyprexa Label ), DUROTEP (View Durotep Review and Durotep Label ), GOSHA JINKI GAN (Unit Dose: 2.5 G) (View Gosha-jinki-gan Review and Gosha-jinki-gan Label ). Patient was hospitalized.

7020105-9 | Ammonia Increased, Anaemia, Diarrhoea, Gastrointestinal Haemorrhage, Hepatic Encephalopathy, Hepatic Function Abnormal, Palmar-plantar Erythrodysaesthesia Syndrome, Platelet Count Decreased
on Sep 21, 2010 Female patient from JAPAN , 69 years of age, weighting 99.21 lb, was diagnosed with hepatic neoplasm malignant and was treated with Nexavar (View Usage). Patient experienced the following unwanted or unexpected effects: ammonia increased, anaemia, diarrhoea, gastrointestinal haemorrhage, hepatic encephalopathy, hepatic function abnormal, palmar-plantar erythrodysaesthesia syndrome, platelet count decreased. Nexavar dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. During the same period patient was treated with LIVACT (Since Before Administration) (View Livact Review and Livact Label ), LOXONIN (Since Before Administration) (View Loxonin Review and Loxonin Label ), TAKEPRON (Since Before Administration) (View Takepron Review and Takepron Label ), TAURINE (Since Before Administration) (View Taurine Review and Taurine Label ), LASIX (Since Before Administration) (View Lasix Review and Lasix Label ), ALDACTONE (Since Before Administration) (View Aldactone Review and Aldactone Label ). Patient was hospitalized.

7020104-7 | Blood Creatine Phosphokinase Increased, Diarrhoea
on Sep 21, 2010 Female patient from JAPAN , 67 years of age, weighting 105.8 lb, was diagnosed with hepatic neoplasm malignant and was treated with Nexavar (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, diarrhoea. Nexavar dosage: Unit Dose: 200 Mg. Patient was hospitalized.

7020103-5 | Bile Duct Cancer
Patient was taking Nexavar (View Usage). After Nexavar was administered, patient had the following side effects: bile duct cancer on Sep 21, 2010 from UNITED STATES Additional patient health information: Female patient , 81 years of age, was diagnosed with hepatic neoplasm malignant and. Nexavar dosage: Total Daily Dose: 400 Mg Unit Dose: 200 Mg.

7020083-2 | Diarrhoea, Hypertension, Hypothyroidism, Malaise, Palmar-plantar Erythrodysaesthesia Syndrome, Reflux Oesophagitis, Renal Cell Carcinoma
Adverse event was reported on Sep 17, 2010 by a Male patient taking Nexavar (View Usage) (Dosage: Unit Dose: 200 Mg) was diagnosed with renal cell carcinoma and. Location: JAPAN , 64 years of age, weighting 119.0 lb, Patient experienced the following unwanted or unexpected effects: diarrhoea, hypertension, hypothyroidism, malaise, palmar-plantar erythrodysaesthesia syndrome, reflux oesophagitis, renal cell carcinoma. During the same period patient was treated with ROHYPNOL (View Rohypnol Review and Rohypnol Label ), ISODINE GARGLE (View Isodine Gargle Review and Isodine Gargle Label ), LOXONIN (View Loxonin Review and Loxonin Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), EURODIN (View Eurodin Review and Eurodin Label ), MYSLEE (View Myslee Review and Myslee Label ). Patient was hospitalized.

7020037-6 | Palmar-plantar Erythrodysaesthesia Syndrome, Platelet Count Decreased, White Blood Cell Count Decreased
on Sep 14, 2010 Male patient from JAPAN , 69 years of age, weighting 132.3 lb, was diagnosed with hepatic neoplasm malignant and was treated with Nexavar (View Usage). Patient had the following side effects: palmar-plantar erythrodysaesthesia syndrome, platelet count decreased, white blood cell count decreased. Nexavar dosage: Unit Dose: 200 Mg.

7018727-4 | Stevens-johnson Syndrome
on Sep 27, 2010 Male patient from JAPAN , 74 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Nexavar (View Usage). After Nexavar was administered, patient had the following side effects: stevens-johnson syndrome. Nexavar dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. Patient was hospitalized.

7018716-X | Abdominal Pain, Gastroenteritis Radiation
Patient was taking Nexavar (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), gastroenteritis radiation on Jul 22, 2010 from SWITZERLAND Additional patient health information: Female patient , 51 years of age, was diagnosed with rectal cancer and. Nexavar dosage: . During the same period patient was treated with CAPECITABINE (View Capecitabine Review and Capecitabine Label ), DOMPERIDON (View Domperidon Review and Domperidon Label ). Patient was hospitalized.

7018715-8 | Hypothyroidism, Thyroiditis
Adverse event was reported on Jul 29, 2010 by a Female patient taking Nexavar (View Usage) (Dosage: Unit Dose: 200 Mg) was diagnosed with renal cell carcinoma, pulmonary hypertension (What is pulmonary hypertension?) and. Location: GERMANY , 53 years of age, Patient had the following side effects: hypothyroidism, thyroiditis. During the same period patient was treated with SUTENT (View Sutent Review and Sutent Label ), AMLODIPINE (1 Day) (View Amlodipine Review and Amlodipine Label ). Patient was hospitalized.

7015484-2 | Hepatic Encephalopathy, Pneumothorax
on Sep 22, 2010 Male patient from SPAIN , 71 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Nexavar (View Usage). After Nexavar was administered, patient had the following side effects: hepatic encephalopathy, pneumothorax. Nexavar dosage: . During the same period patient was treated with PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ). Patient was hospitalized.

7014818-2 | Chest Pain, Dyspepsia, Paraesthesia, Skin Ulcer, Staphylococcal Abscess
on Jul 19, 2010 Male patient from FRANCE , 73 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Nexavar (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), dyspepsia, paraesthesia, skin ulcer, staphylococcal abscess. Nexavar dosage: . During the same period patient was treated with VASTAREL (View Vastarel Review and Vastarel Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), COUMADIN (View Coumadin Review and Coumadin Label ), KARDEGIC (DL LYSINE AC!TYLSALICYLATE) (View Kardegic (dl-lysine Ac!tylsalicylate) Review and Kardegic (dl-lysine Ac!tylsalicylate) Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ). Patient was hospitalized.

7014814-5 | Hypothyroidism, Thyroiditis
Patient was taking Nexavar (View Usage). Patient had the following side effects: hypothyroidism, thyroiditis on Jul 29, 2010 from GERMANY Additional patient health information: Female patient , 53 years of age, was diagnosed with renal cell carcinoma, pulmonary hypertension (What is pulmonary hypertension?) and. Nexavar dosage: Unit Dose: 200 Mg. During the same period patient was treated with SUTENT (View Sutent Review and Sutent Label ), AMLODIPINE (1 Day) (View Amlodipine Review and Amlodipine Label ). Patient was hospitalized.

7014813-3 | Abdominal Pain, Gastroenteritis Radiation
Adverse event was reported on Jul 22, 2010 by a Female patient taking Nexavar (View Usage) (Dosage: ) was diagnosed with rectal cancer and. Location: SWITZERLAND , 51 years of age, After Nexavar was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), gastroenteritis radiation. During the same period patient was treated with CAPECITABINE (View Capecitabine Review and Capecitabine Label ), DOMPERIDON (View Domperidon Review and Domperidon Label ). Patient was hospitalized.

7014643-2 | Cough, Haemoptysis, Nasopharyngitis, Pneumonia
on Sep 20, 2010 Male patient from ITALY , 79 years of age, was diagnosed with renal cell carcinoma and was treated with Nexavar (View Usage). Patient experienced the following unwanted or unexpected effects: cough, haemoptysis, nasopharyngitis, pneumonia (What is pneumonia?). Nexavar dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), TACHIDOL (View Tachidol Review and Tachidol Label ), ALFUZOSIN HCL (View Alfuzosin Hcl Review and Alfuzosin Hcl Label ), CORTONE ACETATO (View Cortone Acetato Review and Cortone Acetato Label ). Patient was hospitalized.

7014642-0 | Ascites, Jaundice
on Sep 20, 2010 Male patient from ITALY , 67 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Nexavar (View Usage). Patient had the following side effects: ascites, jaundice (What is jaundice?). Nexavar dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. During the same period patient was treated with LAEVOLAC (View Laevolac Review and Laevolac Label ), INDERAL (View Inderal Review and Inderal Label ), KANRENOL (View Kanrenol Review and Kanrenol Label ), HUMALOG (View Humalog Review and Humalog Label ). Patient was hospitalized.

7014624-9 | Blood Potassium Decreased, Conduction Disorder
Patient was taking Nexavar (View Usage). After Nexavar was administered, patient had the following side effects: blood potassium decreased, conduction disorder on Sep 16, 2010 from GERMANY Additional patient health information: Male patient , 61 years of age, was diagnosed with hepatic neoplasm malignant, blood potassium decreased and. Nexavar dosage: Total Daily Dose: 400 Mg. During the same period patient was treated with 4SC 201 (Total Daily Dose: 600 Mg) (View 4sc-201 Review and 4sc-201 Label ), KALINOR (View Kalinor Review and Kalinor Label ). Patient was hospitalized.

7012029-8 | Asthenia
Adverse event was reported on Sep 22, 2010 by a Male patient taking Nexavar (View Usage) (Dosage: ) was diagnosed with hepatic neoplasm malignant and. Location: FRANCE , 79 years of age, weighting 130.1 lb, Patient experienced the following unwanted or unexpected effects: asthenia. During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), NISIS (View Nisis Review and Nisis Label ). Patient was hospitalized.

7009860-1 | Atrioventricular Block, Torsade De Pointes
on Aug 16, 2010 Male patient from FRANCE , 70 years of age, weighting 169.8 lb, was diagnosed with hepatic neoplasm malignant and was treated with Nexavar (View Usage). Patient had the following side effects: atrioventricular block, torsade de pointes. Nexavar dosage: . Patient was hospitalized.

7009205-7 | Chest Pain, Dyspepsia, Paraesthesia, Skin Ulcer, Staphylococcal Abscess
on Jul 19, 2010 Male patient from FRANCE , 73 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Nexavar (View Usage). After Nexavar was administered, patient had the following side effects: chest pain (What is chest pain?), dyspepsia, paraesthesia, skin ulcer, staphylococcal abscess. Nexavar dosage: . During the same period patient was treated with VASTAREL (View Vastarel Review and Vastarel Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), COUMADIN (View Coumadin Review and Coumadin Label ), KARDEGIC (DL LYSINE AC!TYLSALICYLATE) (View Kardegic (dl-lysine Ac!tylsalicylate) Review and Kardegic (dl-lysine Ac!tylsalicylate) Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ). Patient was hospitalized.

7009162-3 | Aphasia, Cerebrovascular Accident, Diarrhoea, Gingival Bleeding, Glossodynia, Herpes Zoster, Hiccups, Lip Pain, Oropharyngeal Discomfort
Patient was taking Nexavar (View Usage). Patient experienced the following unwanted or unexpected effects: aphasia (What is aphasia?), cerebrovascular accident, diarrhoea, gingival bleeding, glossodynia, herpes zoster, hiccups, lip pain, oropharyngeal discomfort on Sep 20, 2010 from NETHERLANDS Additional patient health information: Male patient , 58 years of age, was diagnosed with hepatic neoplasm malignant and. Nexavar dosage: .

7009161-1 | Hepatic Encephalopathy
Adverse event was reported on Sep 21, 2010 by a Male patient taking Nexavar (View Usage) (Dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg) was diagnosed with hepatic neoplasm malignant and. Location: JAPAN , 64 years of age, Patient had the following side effects: hepatic encephalopathy. Patient was hospitalized.

7009115-5 | Altered State Of Consciousness, Arterial Thrombosis Limb, Blood Creatine Phosphokinase Increased, Hepatic Function Abnormal, Hepatic Neoplasm Malignant, Hyponatraemia, Rash, Renal Impairment, Rhabdomyolysis
on Sep 17, 2010 Male patient from JAPAN , 71 years of age, weighting 127.9 lb, was diagnosed with hepatic neoplasm malignant, arterial thrombosis limb, abdominal pain (What is abdominal pain?), ileus, disseminated intravascular coagulation and was treated with Nexavar (View Usage). After Nexavar was administered, patient had the following side effects: altered state of consciousness, arterial thrombosis limb, blood creatine phosphokinase increased, hepatic function abnormal, hepatic neoplasm malignant, hyponatraemia, rash (What is rash?), renal impairment, rhabdomyolysis. Nexavar dosage: Total Daily Dose: 400 Mg Unit Dose: 200 Mg. During the same period patient was treated with DIURETICS (View Diuretics Review and Diuretics Label ), SLOVASTAN (View Slovastan Review and Slovastan Label ), OXYCONTIN (Total Daily Dose: 45 Mg) (View Oxycontin Review and Oxycontin Label ), SANDOSTATIN (View Sandostatin Review and Sandostatin Label ), FRESH FROZEN PLASMA (View Fresh Frozen Plasma Review and Fresh Frozen Plasma Label ).

7009103-9 | Hepatic Function Abnormal, Platelet Count Decreased
on Sep 16, 2010 Male patient from JAPAN , 81 years of age, weighting 136.7 lb, was diagnosed with hepatic neoplasm malignant, computerised tomogram abdomen and was treated with Nexavar (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal, platelet count decreased. Nexavar dosage: Total Daily Dose: 400 Mg Unit Dose: 200 Mg. During the same period patient was treated with URSO 250 (View Urso 250 Review and Urso 250 Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), LENDORM (View Lendorm Review and Lendorm Label ), RINDERON DP (View Rinderon-dp Review and Rinderon-dp Label ), OMNIPAQUE 300 (Total Daily Dose: 100 Ml) (View Omnipaque 300 Review and Omnipaque 300 Label ), SEISHOKU (View Seishoku Review and Seishoku Label ).

7009102-7 | Loss Of Consciousness, Palmar-plantar Erythrodysaesthesia Syndrome
Patient was taking Nexavar (View Usage). Patient had the following side effects: loss of consciousness, palmar-plantar erythrodysaesthesia syndrome on Sep 16, 2010 from JAPAN Additional patient health information: Male patient , 80 years of age, was diagnosed with hepatic neoplasm malignant and. Nexavar dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. Patient was hospitalized.

7009085-X |
Adverse event was reported on Sep 16, 2010 by a Female patient taking Nexavar (View Usage) (Dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg) was diagnosed with metastatic renal cell carcinoma, insomnia, blood pressure increased, anaesthesia procedure and. Location: JAPAN , 58 years of age, weighting 154.3 lb, . During the same period patient was treated with INTERFERON (Total Daily Dose: 3 Miu) (View Interferon Review and Interferon Label ), RESLIN (Total Daily Dose: 25 Mg Unit Dose: 25 Mg) (View Reslin Review and Reslin Label ), DIOVAN (Total Daily Dose: 80 Mg Unit Dose: 80 Mg) (View Diovan Review and Diovan Label ), ADALAT CC (Total Daily Dose: 20 Mg Unit Dose: 20 Mg) (View Adalat Cc Review and Adalat Cc Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), FLURBIPROFEN (View Flurbiprofen Review and Flurbiprofen Label ), ESLAX (View Eslax Review and Eslax Label ), PROPOFOL (Unit Dose: 1 %) (View Propofol Review and Propofol Label ).

7009082-4 | Coma Hepatic, Duodenal Perforation
on Sep 14, 2010 Male patient from JAPAN , 67 years of age, weighting 134.5 lb, was diagnosed with hepatic neoplasm malignant and was treated with Nexavar (View Usage). Patient experienced the following unwanted or unexpected effects: coma hepatic, duodenal perforation. Nexavar dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. During the same period patient was treated with URSO 250 (Unit Dose: 100 Mg) (View Urso 250 Review and Urso 250 Label ), NICHIPHAGEN (View Nichiphagen Review and Nichiphagen Label ). Patient was hospitalized.

7009073-3 | Burning Sensation, Dermatitis Bullous, Eyelid Oedema, Nasal Mucosal Disorder, Palmar-plantar Erythrodysaesthesia Syndrome, Rhinalgia
on Sep 09, 2010 Male patient from FRANCE , 74 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Nexavar (View Usage). Patient had the following side effects: burning sensation, dermatitis bullous, eyelid oedema, nasal mucosal disorder, palmar-plantar erythrodysaesthesia syndrome, rhinalgia. Nexavar dosage: Total Daily Dose: 800 Mg. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), TAHOR (View Tahor Review and Tahor Label ), TRIVASTAL (View Trivastal Review and Trivastal Label ), MECIR (View Mecir Review and Mecir Label ).

7007335-7 | Ascites, Diarrhoea, Hepatic Function Abnormal, Hypertension, Palmar-plantar Erythrodysaesthesia Syndrome
Patient was taking Nexavar (View Usage). After Nexavar was administered, patient had the following side effects: ascites, diarrhoea, hepatic function abnormal, hypertension, palmar-plantar erythrodysaesthesia syndrome on Sep 21, 2010 from JAPAN Additional patient health information: Male patient , 67 years of age, weighting 121.3 lb, was diagnosed with hepatic neoplasm malignant and. Nexavar dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg.

7007334-5 | Blood Bilirubin Increased, Hepatic Function Abnormal, Hepatic Neoplasm Malignant, Hyperamylasaemia, Palmar-plantar Erythrodysaesthesia Syndrome
Adverse event was reported on Sep 21, 2010 by a Male patient taking Nexavar (View Usage) (Dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg) was diagnosed with hepatic neoplasm malignant, prophylaxis and. Location: JAPAN , 55 years of age, weighting 160.9 lb, Patient experienced the following unwanted or unexpected effects: blood bilirubin increased, hepatic function abnormal, hepatic neoplasm malignant, hyperamylasaemia, palmar-plantar erythrodysaesthesia syndrome. During the same period patient was treated with UREPEARL (View Urepearl Review and Urepearl Label ), ZEFIX (Since Before Administration) (View Zefix Review and Zefix Label ), HEPSERA (Since Before Administration) (View Hepsera Review and Hepsera Label ), TAGAMET (Since Before Administration) (View Tagamet Review and Tagamet Label ). Patient was hospitalized.

7007322-9 | Asthenia, Blood Creatine Phosphokinase Increased, Decreased Appetite, Fatigue, Hepatic Encephalopathy, Hepatic Function Abnormal, Nausea, Palmar-plantar Erythrodysaesthesia Syndrome, Parkinsonism
on Sep 17, 2010 Male patient from JAPAN , 54 years of age, weighting 176.4 lb, was diagnosed with hepatic neoplasm malignant, prophylaxis of nausea and vomiting, disbacteriosis and was treated with Nexavar (View Usage). Patient had the following side effects: asthenia, blood creatine phosphokinase increased, decreased appetite, fatigue, hepatic encephalopathy, hepatic function abnormal, nausea (What is nausea?), palmar-plantar erythrodysaesthesia syndrome, parkinsonism. Nexavar dosage: Unit Dose: 200 Mg. During the same period patient was treated with NOVAMIN (Total Daily Dose: 15 Mg Unit Dose: 5 Mg) (View Novamin Review and Novamin Label ), OMEPRAL (Total Daily Dose: 20 Mg Unit Dose: 20 Mg) (View Omepral Review and Omepral Label ), LENDORMIN D (Total Daily Dose: 0.25 Mg Unit Dose: 0.25 Mg) (View Lendormin D Review and Lendormin D Label ), BIOFERMIN (Total Daily Dose: 3 Df) (View Biofermin Review and Biofermin Label ), URSO 250 (Total Daily Dose: 300 Mg) (View Urso 250 Review and Urso 250 Label ), STROCAIN (Total Daily Dose: 15 Mg Unit Dose: 5 Mg) (View Strocain Review and Strocain Label ), MAALOX (Total Daily Dose: 3.6 G Unit Dose: 1.2 G) (View Maalox Review and Maalox Label ), UREPEARL (Since Before Administration) (View Urepearl Review and Urepearl Label ). Patient was hospitalized.

7007320-5 | Alopecia, Erythema, Palmar-plantar Erythrodysaesthesia Syndrome, Thrombosis, White Blood Cell Count Decreased
on Sep 17, 2010 Female patient from JAPAN , 76 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Nexavar (View Usage). After Nexavar was administered, patient had the following side effects: alopecia, erythema, palmar-plantar erythrodysaesthesia syndrome, thrombosis, white blood cell count decreased. Nexavar dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg.

7007319-9 | Gastrointestinal Haemorrhage, Hepatic Encephalopathy
Patient was taking Nexavar (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal haemorrhage, hepatic encephalopathy on Sep 17, 2010 from JAPAN Additional patient health information: Male patient , 77 years of age, was diagnosed with hepatic neoplasm malignant and. Nexavar dosage: . During the same period patient was treated with WARFARIN (View Warfarin Review and Warfarin Label ).

7007249-2 | Abdominal Discomfort, Alopecia, Burning Sensation, Constipation, Diarrhoea, Dry Skin, Dyspepsia, Eczema, Gastrointestinal Hypermotility
Adverse event was reported on Sep 16, 2010 by a Male patient taking Nexavar (View Usage) (Dosage: ) . Location: BELGIUM , weighting 160.9 lb, Patient had the following side effects: abdominal discomfort, alopecia, burning sensation, constipation (What is constipation?), diarrhoea, dry skin, dyspepsia, eczema (What is eczema?), gastrointestinal hypermotility.

7007248-0 | Bone Marrow Failure, Haemoglobin Decreased, Hepatic Neoplasm Malignant, Hypertension, Oedema Peripheral
on Sep 17, 2010 Female patient from JAPAN , 85 years of age, weighting 123.5 lb, was diagnosed with hepatic neoplasm malignant and was treated with Nexavar (View Usage). After Nexavar was administered, patient had the following side effects: bone marrow failure, haemoglobin decreased, hepatic neoplasm malignant, hypertension, oedema peripheral. Nexavar dosage: Unit Dose: 200 Mg. During the same period patient was treated with DIURETICS (View Diuretics Review and Diuretics Label ), AMLODIN OD (Unit Dose: 5 Mg) (View Amlodin Od Review and Amlodin Od Label ), AMLODIPINE BESYLATE (Unit Dose: 2.5 Mg) (View Amlodipine Besylate Review and Amlodipine Besylate Label ), BLOPRESS (Unit Dose: 8 Mg) (View Blopress Review and Blopress Label ).

7007247-9 | Cancer Pain, Hepatic Function Abnormal, Intra-abdominal Haemorrhage
on Sep 17, 2010 Male patient from JAPAN , 64 years of age, weighting 158.7 lb, was diagnosed with hepatic neoplasm malignant and was treated with Nexavar (View Usage). Patient experienced the following unwanted or unexpected effects: cancer pain, hepatic function abnormal, intra-abdominal haemorrhage. Nexavar dosage: Total Daily Dose: 800 Mg Unit Dose: 200 Mg. During the same period patient was treated with URSO 250 (Since Before Nexavar Administration) (View Urso 250 Review and Urso 250 Label ), TAKEPRON (Since Before Nexavar Administration) (View Takepron Review and Takepron Label ), MUCOSTA (Since Before Nexavar Administration) (View Mucosta Review and Mucosta Label ), LASIX (Since Before Nexavar Administration) (View Lasix Review and Lasix Label ), AMARYL (Since Before Nexavar Administration) (View Amaryl Review and Amaryl Label ), BASEN OD (Since Before Nexavar Administration) (View Basen Od Review and Basen Od Label ).

7007225-X | Coma Hepatic
Patient was taking Nexavar (View Usage). Patient had the following side effects: coma hepatic on Sep 16, 2010 from JAPAN Additional patient health information: Male patient , 61 years of age, was diagnosed with hepatic neoplasm malignant and. Nexavar dosage: Unit Dose: 200 Mg.